Flovent Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Funding
• Alerts
• Clinical Trials

Pharmacokinetic Profile and Safety of Fluticasone Propionate and Albuterol Sulfate in Combination When Compared to Fluticasone Propionate Multidose Dry Powder Inhaler (Fp MDPI) in Children Aged 4 to 11 Years Old
Conditions: Asthma Interventions: Drug: TEV-56248; Drug: Fp MDPI Sponsors: Teva Branded Pharmaceutical Products R&D, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 4, 2024 Category: Research Source Type: clinical trials

BIOEQUIVALENCE STUDY OF AZELASTINE HYDROCHLORIDE/ FLUTICASONE PROPIONATE 137 Microgram/50 Microgram NASAL SPRAY AND'DYMISTA' (AZELASTINE HYDROCHLORIDE/ FLUTICASONE PROPIONATE) NASAL SPRAY 137 Microgram/50 Microgram
Conditions: Seasonal Allergic Rhinitis; Perennial Allergic Rhinitis Interventions: Drug: Azelastine Hydrochloride/ Fluticasone propionate nasal spray; Drug: ' DYMISTA ' NASAL SPRAY Sponsors: Humanis Sagl ık Anonim Sirketi Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 22, 2023 Category: Research Source Type: clinical trials

A Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol Sulfate is Effective in Preventing Asthma Exacerbations
Condition:   Asthma Interventions:   Drug: TEV-56248;   Drug: Albuterol sulfate Sponsor:   Teva Branded Pharmaceutical Products R&D,  Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 25, 2023 Category: Research Source Type: clinical trials

A Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol Sulfate is Effective in Preventing Asthma Exacerbations
Conditions: Asthma Interventions: Drug: TEV-56248; Drug: Albuterol sulfate Sponsors: Teva Branded Pharmaceutical Products R&D, Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 25, 2023 Category: Research Source Type: clinical trials

Bioequivalence Study for Fluticasone Propionate 500 mcg/Salmeterol Xinafoate 50 mcg Inhalation Powder in Healthy Volunteers
Condition:   Bioequivalence Interventions:   Drug: Fluticasone propionate 500 mcg and salmeterol xinafoate 50 mcg/Respirent Pharmaceuticals;   Drug: ADVAIR DISKUS® 500/50 Sponsors:   Respirent Pharmaceuticals Co Ltd.;   Becro Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 6, 2023 Category: Research Source Type: clinical trials